Heron Therapeutics, Inc. · NASDAQ:HRTX

Collard Craig A exercised options for 62,500 Heron Therapeutics, Inc. shares (Form 4)

Traded Apr 3, 2026 · Filed Apr 6, 2026

On Apr 3, 2026, Collard Craig A (Director, Chief Executive Officer) exercised options for 62,500 Heron Therapeutics, Inc. shares, leaving 648,255 shares. Filed Apr 6, 2026 (Form 4).

Options exercised
62,500 shares
Holding after
648,255 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 3, 2026Common StockOption exercise62,500648,255Direct

Source

View original at SEC

Related